Insider selling
Traded Oct 15, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Keros Therapeutics sold $40.6M of Keros Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 15, 2025 · Filed Oct 15, 2025
A major shareholder of Keros Therapeutics sold $13.2M of Keros Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$13,194,605
Shares × reported transaction price
on the day of results (Oct 15, 2025), 21 days before results of Nov 5, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $14.49 on Oct 15, 2025, 52% above its 52-week low and 79% below its high, after an 8% drop over the previous 30 trading days
52-week range $9.55 (Apr 1, 2025) to $70.00 (Dec 6, 2024), 8% of the way up, from 250 adjusted closes. 30 trading days earlier: $15.76 on Sep 3, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +8.3% | +1.7% | +6.6% |
| 30 days | +26.4% | +0.8% | +25.7% |
| 90 days | +42.1% | +4.5% | +37.6% |
| 180 days | −15.9% | +5.1% | −21.1% |
| 365 days | −22.4% | +15.5% | −38.0% |
Past results only. Not a forecast.
Insider selling
Traded Oct 15, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Keros Therapeutics sold $40.6M of Keros Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Oct 15, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Keros Therapeutics sold $19.9M of Keros Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Oct 15, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Keros Therapeutics sold $21.8M of Keros Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.